HUTCHMED (China) Ltd (HCM) Down 5.07% in Premarket Trading

HUTCHMED (China) Ltd (HCM) has fallen Wednesday morning, with the stock declining -5.07% in pre-market trading to 13.3. HCM's short-term technical score of 39 indicates that the stock has traded less bullishly over the last month than 61% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 105 out of 146 industries, the stock ranks higher than 55% of stocks. HUTCHMED (China) Ltd has fallen 14.94% over the past month, closing at $15.03 on January 17. During this period of time, the stock fell as low as $12.08 and as high as $15.51. HCM has an average analyst recommendation of Strong Buy. The company has an average price target of $25.54.

HCM has an Overall Score of 45. Find out what this means to you and get the rest of the rankings on HCM!

See Full HCM Report

HUTCHMED (China) Ltd has a Long-Term Technical rank of 21. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 79% of the market scoring higher. In the Drug Manufacturers - Specialty & Generic industry which is number 111 by this metric, HCM ranks better than 111% of stocks.

Important Dates for Investors in HCM:

-HUTCHMED (China) Ltd is set to release earnings on 2024-02-28. Over the last 12 months, the company has reported EPS of $-0.25. -We do not have a set dividend date for HUTCHMED (China) Ltd at this time. Click Here To Get The Full Report on HUTCHMED (China) Ltd (HCM)